RS-0826
N/A
Report date: 2025/12/26 15:51:33
Base Information
Drug NameRS-0826
Drug Alias Name
Classification +[6]
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesRs Research
China Registration ClassN/A
Develop Information
Active CompaniesPDC Therapeutics IncRs Research
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A